Impact of marital status on the prognosis of liver cancer patients without surgery and the critical window

被引:18
作者
Liang, Yuehui [1 ]
Wu, Xinyin [1 ]
Lu, Chan [1 ,2 ]
Xiao, Fang [1 ]
机构
[1] Cent South Univ, Xiangya Sch Publ Hlth, 238 Shangmayuanling Rd, Changsha 410078, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Early Life Dev & Dis Prevent, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
Liver cancer (LC); marriage; prognosis; social support; survival analysis; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; SOCIAL SUPPORT; TRANSARTERIAL CHEMOEMBOLIZATION; DOUBLE-BLIND; SURVIVAL; DIAGNOSIS; STAGE; OUTCOMES; WOMEN;
D O I
10.21037/apm-20-1885
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Liver cancer (LC) is the second leading cause of cancer-associated mortality. However, the critical time window during the marital status may influence the prognosis of LC is still unknown. Methods: Information on a total of 4,933 patients diagnosed with primary LC who had not undergone surgery was collected from the Surveillance, Epidemiology, and End Results (SEER) database to analyze the impact of marital status on the risk of cancer-specific mortality (CSM). All confirmed patients were monitored from January 1, 2010 until December 31, 2015 for the occurrence of death. We performed 1:1 propensity score matching among the married and non-married groups to eliminate dissimilarities in age, sex, race and clinical characteristics. Cox proportional hazards regression model was adopted to investigate the associations between marital status and the risk of CSM. Results: Married patients were significantly negatively associated with the risk of CSM among patients compared to non-married status, with a hazard ratio (HR) [95% confidence interval (CI)] of 1.15 (1.07-1.23). The strongest associations were observed for patients with Grade II, American Joint Committee on Cancer (AJCC) I and III. Furthermore, the protective effect of marriage on the prognosis of LC was independent of sex, age, race, grade, AJCC and SEER stage. Unmarried or separated patients may have a worse prognosis. Conclusions: Marriage was strongly associated with a positive prognosis among patients with LC, especially in the critical window of Grade II, AJCC I and III. This study highlights the important impact of marriage on cancer prognosis.
引用
收藏
页码:2990 / +
页数:11
相关论文
共 41 条
[1]   Marital Status and Survival in Patients With Cancer [J].
Aizer, Ayal A. ;
Chen, Ming-Hui ;
McCarthy, Ellen P. ;
Mendu, Mallika L. ;
Koo, Sophia ;
Wilhite, Tyler J. ;
Graham, Powell L. ;
Choueiri, Toni K. ;
Hoffman, Karen E. ;
Martin, Neil E. ;
Hu, Jim C. ;
Nguyen, Paul L. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) :3869-3876
[2]   The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].
Akinyemiju, Tomi ;
Abera, Semaw ;
Ahmed, Muktar ;
Alam, Noore ;
Alemayohu, Mulubirhan Assefa ;
Allen, Christine ;
Al-Raddadi, Rajaa ;
Alvis-Guzman, Nelson ;
Amoako, Yaw ;
Artaman, Al ;
Ayele, Tadesse Awoke ;
Barac, Aleksandra ;
Bensenor, Isabela ;
Berhane, Adugnaw ;
Bhutta, Zulfiqar ;
Castillo-Rivas, Jacqueline ;
Chitheer, Abdulaal ;
Choi, Jee-Young ;
Cowie, Benjamin ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dey, Subhojit ;
Dicker, Daniel ;
Phuc, Huyen ;
Ekwueme, Donatus U. ;
Zaki, Maysaa El Sayed ;
Fischer, Florian ;
Furst, Thomas ;
Hancock, Jamie ;
Hay, Simon I. ;
Hotez, Peter ;
Jee, Sun Ha ;
Kasaeian, Amir ;
Khader, Yousef ;
Khang, Young-Ho ;
Kumar, G. Anil ;
Kutz, Michael ;
Larson, Heidi ;
Lopez, Alan ;
Lunevicius, Raimundas ;
Malekzadeh, Reza ;
McAlinden, Colm ;
Meier, Toni ;
Mendoza, Walter ;
Mokdad, Ali ;
Moradi-Lakeh, Maziar ;
Nagel, Gabriele ;
Nguyen, Quyen ;
Nguyen, Grant ;
Ogbo, Felix .
JAMA ONCOLOGY, 2017, 3 (12) :1683-1691
[3]   Optimism, social support, and mental health outcomes in patients with advanced cancer [J].
Applebaum, Allison J. ;
Stein, Emma M. ;
Lord-Bessen, Jennifer ;
Pessin, Hayley ;
Rosenfeld, Barry ;
Breitbart, William .
PSYCHO-ONCOLOGY, 2014, 23 (03) :299-306
[4]   Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study [J].
Bai, Wei ;
Wang, Yong Ji ;
Zhao, Yan ;
Qi, Xing Shun ;
Yin, Zhan Xin ;
He, Chuang Ye ;
Li, Rui Jun ;
Wu, Kai Chun ;
Xia, Jie Lai ;
Fan, Dai Ming ;
Han, Guo Hong .
JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (04) :181-190
[5]   Using the National Cancer Database for Outcomes Research [J].
Boffa, Daniel J. ;
Rosen, Joshua E. ;
Mallin, Katherine ;
Loomis, Ashley ;
Gay, Greer ;
Palis, Bryan ;
Thoburn, Kathleen ;
Gress, Donna ;
McKellar, Daniel P. ;
Shulman, Lawrence N. ;
Facktor, Matthew A. ;
Winchester, David P. .
JAMA ONCOLOGY, 2017, 3 (12) :1722-1728
[6]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[7]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[8]   Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma [J].
Bruix, Jordi ;
Reig, Maria ;
Sherman, Morris .
GASTROENTEROLOGY, 2016, 150 (04) :835-853
[9]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[10]   Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009 [J].
Dinan, Michaela A. ;
Mi, Xiaojuan ;
Reed, Shelby D. ;
Hirsch, Bradford R. ;
Lyman, Gary H. ;
Curtis, Lesley H. .
JAMA ONCOLOGY, 2015, 1 (02) :158-166